- Page 3: Abstractbook 2010 8 th Annual Meeti
- Page 7 and 8: Managing Committee: Christoph Huber
- Page 9 and 10: Visit our website www.cimt.eu find
- Page 11 and 12: 2010 Speakers: G. J. Adema Radboud
- Page 13 and 14: 2010 Speakers: D. I. Gabrilovich Un
- Page 15 and 16: 2010 Speakers: Weiping Zou Departme
- Page 17 and 18: 16:05-16:20 K. Laske (Tuebingen) (#
- Page 19 and 20: 11:05-11:20 M. Koslowski (Mainz) (#
- Page 21 and 22: Session 7: Poised, Suppressed, Tole
- Page 23 and 24: Industry exhibitors R&D Systems CTL
- Page 25 and 26: Guided Poster Sessions Session Date
- Page 27 and 28: Abstract Nr. Title 011 Kuhs 012 Gue
- Page 29 and 30: Abstract Nr. Title L124 Zhang 031 G
- Page 31 and 32: Abstract Nr. Title 051 Distler 052
- Page 33 and 34: Abstract Nr. Title 071 Kleemann 072
- Page 35 and 36: Abstract Nr. Title 091 Ramacher 092
- Page 37 and 38: Abstract Nr. Title 111 Diekmann 112
- Page 39 and 40: 001 Bontkes | Therapeutic vaccinati
- Page 41 and 42: 003 Altvater | Therapeutic vaccinat
- Page 43 and 44: 005 Vyth-Dreese | Therapeutic vacci
- Page 45 and 46: 007 Navarrete | Therapeutic vaccina
- Page 47 and 48: 009 Kuhn | Therapeutic vaccination
- Page 49 and 50: 011 Kuhs | Therapeutic vaccination
- Page 51 and 52: 013 Babiarova | Therapeutic vaccina
- Page 53 and 54: 015 Vogt | Therapeutic vaccination
- Page 55 and 56:
017 Schaft | Therapeutic vaccinatio
- Page 57 and 58:
019 Buhl | Therapeutic vaccination
- Page 59 and 60:
L119 Dutoit | Therapeutic vaccinati
- Page 61 and 62:
L121 Pawlowski | Therapeutic vaccin
- Page 63 and 64:
Immune monitoring 61
- Page 65 and 66:
022 Pfirschke | Immune monitoring T
- Page 67 and 68:
024 Zupke | Immune monitoring Nanop
- Page 69 and 70:
026 Tanriverdi-Akhisaroglu | Immune
- Page 71 and 72:
028 Laske | Immune monitoring T-cel
- Page 73 and 74:
030 Brix | Immune monitoring MHC De
- Page 76 and 77:
031 Gross | Immune monitoring Monit
- Page 78 and 79:
033 Singh | Immune monitoring A sta
- Page 80 and 81:
035 Voland | Immune monitoring Char
- Page 82 and 83:
037 Aarntzen | Immune monitoring Sk
- Page 84 and 85:
039 Attig | Immune monitoring Recom
- Page 86 and 87:
040 Kotsiou | Cellular therapy Appl
- Page 88 and 89:
042 Weigand | Cellular therapy Gene
- Page 90 and 91:
044 Kalos | Cellular therapy Cleara
- Page 92 and 93:
046 Singh | Cellular therapy Search
- Page 94 and 95:
048 Schendel | Cellular therapy Hig
- Page 96 and 97:
050 Klobuch | Cellular therapy T ce
- Page 98 and 99:
052 Salguero | Cellular therapy Dra
- Page 100 and 101:
054 Bloetz | Cellular therapy Allo-
- Page 102 and 103:
056 Hoyer | Cellular therapy Examin
- Page 104 and 105:
058 Echchannaoui | Cellular therapy
- Page 106 and 107:
060 Schmitt | Cellular therapy WT1
- Page 108 and 109:
061 Buchwald | New targets & new le
- Page 110 and 111:
063 Domning | New targets & new lea
- Page 112 and 113:
065 Casares | New targets & new lea
- Page 114 and 115:
067 Hirschhaeuser | New targets & n
- Page 116 and 117:
069 Sørensen | New targets & new l
- Page 118 and 119:
071 Kleemann | New targets & new le
- Page 120 and 121:
073 Suso | New targets & new leads
- Page 122 and 123:
075 Lubojanski | New targets & new
- Page 124 and 125:
077 Feger | New targets & new leads
- Page 126 and 127:
L125 Huijbers | New targets & new l
- Page 128 and 129:
126 Tumor biology & interaction wit
- Page 130 and 131:
079 Poschke | Tumor biology & inter
- Page 132 and 133:
081 Lion | Tumor biology & interact
- Page 134 and 135:
083 Ge | Tumor biology & interactio
- Page 136 and 137:
085 Dubrot | Tumor biology & intera
- Page 138 and 139:
087 Lutz-Nicoladoni | Tumor biology
- Page 140 and 141:
089 Sha | Tumor biology & interacti
- Page 142 and 143:
091 Ramacher | Tumor biology & inte
- Page 144 and 145:
093 Koslowski | Tumor biology & int
- Page 146 and 147:
095 Lanzardo | Tumor biology & inte
- Page 148 and 149:
097 Fraszczak | Tumor biology & int
- Page 150 and 151:
099 Hemmerling | Tumor biology & in
- Page 152 and 153:
101 Karakhanova | Tumor biology & i
- Page 154 and 155:
103 Heidemann Krogh | Tumor biology
- Page 156 and 157:
105 Lupp | Tumor biology & interact
- Page 158 and 159:
156 Enhancing immunity & adjuvants
- Page 160 and 161:
108 Diaz-Valdés | Enhancing immuni
- Page 162 and 163:
110 Femel | Enhancing immunity & ad
- Page 164 and 165:
112 Reinis | Enhancing immunity & a
- Page 166 and 167:
114 Lehmann | Enhancing immunity &
- Page 168 and 169:
116 Hotz | Enhancing immunity & adj
- Page 170 and 171:
118 Trojandt | Enhancing immunity &
- Page 172 and 173:
Imprint Postal Address CIMT - Assoc